The "RNA world" hypothesis proposes that the earliest life on Earth may have been based on RNA—a single-stranded molecule ...

Researchers discovered alcohol use disorder (AUD) and Alzheimer's disease (AD) exhibit similar patterns of gene dysregulation ...

CAMP4 Therapeutics raises $75 million in IPO, advances RNA therapies for rare diseases, and partners with BioMarin. Analysts ...

Could the controversial COVID drug hydroxychloroquine be repurposed as a promising medication for cancer? Researchers believe ...

Think back to that basic biology class you took in high school. You probably learned about organelles, those little "organs" ...

VIR's HDV and HBV treatments remain Vir's primary value drivers, with upcoming catalysts in Q4 2024 and 2025. Find out why ...

Researchers from the UCLA Samueli School of Engineering and the University of Rome Tor Vergata in Italy have developed ...

As a key player in protein synthesis, mRNA technology is transforming therapeutics, offering solutions for cancer, genetic disorders, and regenerative medicine.

Membraneless organelles, also called biomolecular condensates, are changing how scientists think about protein chemistry, ...

The following is a summary of “Multi-scalar data integration decoding risk genes for chronic kidney disease,” published in the October 2024 issue of Nephrology by Ding et al. Chronic Kidney Disease ...

TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that it has received notice from The Nasdaq ...

The median was $250,000. A 27.1% RNA rate represents the 64 horses who failed to meet their reserve. Last year's sale saw 154 ...